FDA panel finds ban on menthol cigarettes would ‘benefit the public health’

Source: www.washingtonpost.com Author: Lyndsey Layton An advisory panel to the Food and Drug Administration that has been studying whether the government ought to ban menthol cigarettes said Friday that the “removal of menthol cigarettes from the marketplace would benefit the public health.” The panel, made up of scientists, doctors and public health experts, stopped short of recommending a ban on menthol cigarettes, which make up about 30 percent of the $80 billion U.S. cigarette market. The committee, which spent a year analyzing menthol cigarettes before releasing its draft recommendations, said that compared to standard cigarettes, the mint-flavored products do not pose greater individual risk to smokers in terms of lung cancer, stroke and other tobacco-related diseases. But menthol cigarettes are especially enticing to teenagers and to blacks and are more likely to turn them into lifetime smokers, the panel found. Smokers of menthol cigarettes also find it harder to quit, the panel said. Lawrence R. Deyton, director of the FDA’s Center for Tobacco Products, said the agency will review the panel’s recommendations. The FDA is not required to follow the advice of its advisory panels but often does. “Now it’s up to us to do our job,” Deyton told the panel. The menthol question will be the first real test of how aggressively the FDA intends to regulate tobacco. Congress passed landmark legislation in 2009 that put tobacco under the authority of the FDA for the first time. The law prohibits the agency from outlawing tobacco or nicotine but gives [...]